Takeda Pharmaceutical
306 hedge funds and large institutions have $1.26B invested in Takeda Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 64 increasing their positions, 126 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0.49% more ownership
Funds ownership: 5.08% → 5.58% (+0.49%)
2% less funds holding
Funds holding: 312 → 306 (-6)
49% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 126
Holders
306
Holding in Top 10
5
Calls
$30.7M
Puts
$1.23M
Top Buyers
| 1 | +$63.7M | |
| 2 | +$58.3M | |
| 3 | +$39M | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$13.9M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$12.1M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$18.7M | |
| 3 | -$12.8M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.07M |
| 5 |
Goldman Sachs
New York
|
-$7.81M |